Tonix Pharmaceuticals (TNXP) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free TNXP Stock Alerts $0.20 +0.02 (+11.29%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Tonix Pharmaceuticals Short Interest DataCurrent Short Volume1,600,000 sharesPrevious Short Volume1,490,000 sharesChange Vs. Previous Month+7.38%Dollar Volume Sold Short$287,040.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 30, 2024Outstanding Shares95,540,000 sharesFloat Size84,490,000 sharesShort Percent of Float1.89%Today's Trading Volume7,240,516 sharesAverage Trading Volume1,723,055 sharesToday's Volume Vs. Average420% Short Selling Tonix Pharmaceuticals ? Sign up to receive the latest short interest report for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTNXP Short Interest Over TimeTNXP Days to Cover Over TimeTNXP Percentage of Float Shorted Over Time Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Tonix Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,600,000 shares $287,040.00 +7.4%1.9%0.7 $0.18 4/15/20241,490,000 shares $217,391.00 +19.2%1.8%0.7 $0.15 3/31/20241,250,000 shares $232,500.00 +29.3%1.5%0.6 $0.19 3/15/2024967,000 shares $310,407.00 +56.9%1.2%0.6 $0.32 2/29/2024616,200 shares $233,046.84 +3.3%0.8%0.3 $0.38 2/15/2024596,500 shares $230,249.00 -6.5%0.7%0.3 $0.39 Get the Latest News and Ratings for TNXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024638,200 shares $204,224.00 +132.1%0.8%0.4 $0.32 1/15/2024275,000 shares $81,455.00 -20.4%0.3%0.2 $0.30 12/31/2023345,300 shares $139,155.90 -77.0%0.6%0.3 $0.40 12/15/20231,500,000 shares $857,700.00 +308.7%5.6%1.4 $0.57 11/30/2023367,000 shares $190,106.00 +270.0%1.5%0.7 $0.52 11/15/202399,200 shares $46,723.20 -70.1%0.4%0.3 $0.47 10/31/2023331,600 shares $195,644.00 +21.2%1.2%1.1 $0.59 10/15/2023273,600 shares $159,727.68 -31.4%1.0%0.6 $0.58 9/30/2023398,700 shares $217,291.50 +277.9%2.3%0.9 $0.55 9/15/2023105,500 shares $97,060.00 -65.5%0.6%0.3 $0.92 8/31/2023305,600 shares $295,331.84 -33.3%1.7%0.7 $0.97 8/15/2023458,200 shares $439,093.06 -71.5%2.6%1 $0.96 7/31/20231,610,000 shares $1.72 million +12.6%15.0%3.4 $1.07 7/15/20231,430,000 shares $2.52 million -4.7%13.9%5.3 $1.76 6/30/20231,500,000 shares $2.37 million +32.7%14.5%5.5 $1.58 6/15/20231,130,000 shares $2.17 million +13.4%11.0%4.5 $1.92 5/31/2023996,900 shares $1.78 million +56.1%9.7%4.5 $1.79 5/15/2023638,800 shares $1.23 million +167.6%6.2%2.9 $1.92 4/30/20231,490,000 shares $774,800.00 +2.8%2.4%1.3 $0.52 4/15/20231,450,000 shares $745,445.00 -42.0%2.3%1 $0.51 3/31/20232,500,000 shares $1.48 million -18.6%4.0%0.9 $0.59 3/15/20233,070,000 shares $1.73 million +15.9%4.9%0.8 $0.56 2/28/20232,650,000 shares $1.86 million -27.0%4.4%0.4 $0.70 2/15/20233,630,000 shares $3.88 million -14.6%6.0%0.5 $1.07 1/31/20234,250,000 shares $4.76 million -24.9%7.4%0.6 $1.12 1/15/20235,660,000 shares $7.36 million +68.5%9.8%0.9 $1.30 12/30/20223,360,000 shares $1.31 million -21.5%5.8%0.6 $0.39 12/15/20224,280,000 shares $1.39 million +210.1%7.4%1 $0.33 11/30/20221,380,000 shares $531,300.00 +123.2%2.4%0.8 $0.39 11/15/2022618,200 shares $306,009.00 -34.6%1.1%0.3 $0.50 10/31/2022945,400 shares $426,375.40 -16.3%1.7%0.4 $0.45 10/15/20221,130,000 shares $541,835.00 +1.8%2.5%0.2 $0.48 9/30/20221,110,000 shares $592,962.00 -41.6%2.5%0.2 $0.53 9/15/20221,900,000 shares $1.64 million -20.8%4.2%0.3 $0.86Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. TNXP Short Interest - Frequently Asked Questions What is Tonix Pharmaceuticals' current short interest? Short interest is the volume of Tonix Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,600,000 shares of TNXP short. 1.89% of Tonix Pharmaceuticals' shares are currently sold short. Learn More on Tonix Pharmaceuticals' current short interest. What is a good short interest ratio for Tonix Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNXP shares currently have a short interest ratio of 1.0. Learn More on Tonix Pharmaceuticals's short interest ratio. What is a good short interest percentage for Tonix Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.89% of Tonix Pharmaceuticals' floating shares are currently sold short. Is Tonix Pharmaceuticals' short interest increasing or decreasing? Tonix Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,600,000 shares, an increase of 7.4% from the previous total of 1,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tonix Pharmaceuticals' float size? Tonix Pharmaceuticals currently has issued a total of 95,540,000 shares. Some of Tonix Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tonix Pharmaceuticals currently has a public float of 84,490,000 shares. How does Tonix Pharmaceuticals' short interest compare to its competitors? 1.89% of Tonix Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tonix Pharmaceuticals: NeuroSense Therapeutics Ltd. (0.16%), Edesa Biotech, Inc. (0.69%), Vincerx Pharma, Inc. (5.98%), Flora Growth Corp. (1.40%), FSD Pharma Inc. (1.00%), Pieris Pharmaceuticals, Inc. (1.12%), RedHill Biopharma Ltd. (2.38%), Purple Biotech Ltd (1.18%), Kiora Pharmaceuticals, Inc. (0.56%), Talphera, Inc. (0.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Tonix Pharmaceuticals stock? Short selling TNXP is an investing strategy that aims to generate trading profit from Tonix Pharmaceuticals as its price is falling. TNXP shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tonix Pharmaceuticals? A short squeeze for Tonix Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNXP, which in turn drives the price of the stock up even further. How often is Tonix Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNXP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NRSN Short Interest Data EDSA Short Interest Data VINC Short Interest Data FLGC Short Interest Data HUGE Short Interest Data PIRS Short Interest Data RDHL Short Interest Data PPBT Short Interest Data KPRX Short Interest Data TLPH Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNXP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHow Biden has already won 2024Porter & Company